<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-vaccines-08-00197">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>DiLillo</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>G.S.</given-names>
   </name>
   <name>
    <surname>Palese</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Ravetch</surname>
    <given-names>J.V.</given-names>
   </name>
  </person-group>
  <article-title>Broadly neutralizing hemagglutinin stalk-specific antibodies require FcÎ³R interactions for protection against influenza virus in vivo</article-title>
  <source>Nat. Med.</source>
  <year>2014</year>
  <volume>20</volume>
  <fpage>143</fpage>
  <lpage>151</lpage>
  <pub-id pub-id-type="doi">10.1038/nm.3443</pub-id>
  <?supplied-pmid 24412922?>
  <pub-id pub-id-type="pmid">24412922</pub-id>
 </element-citation>
</ref>
